SILK

SILK

SILK

Letters With This Ticker

Quarter Letter Date Fund Name QTD YTD Tickers Keywords/Themes Theme Commentary Pitches Letter
2023 Q4 Dec 31, 2023 NCG Small Cap Growth Strategy 4.8% 14.8% BRZE, CSTL, CWAN, DAVA, FLYW, GWRE, KNSL, LGIH, MEDP, NTRA, SILK, TMDX, TNDM, VRRM Biotechnology, Fed Pivot, growth, healthcare, market breadth, small caps CSTL
TNDM
ASIC|CWAN|INSP|KRMN|KTOS|MAC|MEG|RH|WYNN
NTRA
ARGX BB|DAVA|DDOG|GLOB|ILMN|LOAR|MELI|NET|NU|NVDA|TSM
ACGL|APH|COO|CSGP|DKNG|GWRE|IDXX|IOT|IT|LPLA|MSCI|MTD|PCOR|ROP|TECH|VRSK
BRZE
MEDP
2023 Q3 Sep 30, 2023 Baron Discovery Fund 13.5% 9.3% AEIS, AXNX, AXON, BYD, CWAN, EWCZ, GTLB, GTLS, GWRE, INDI, KNSL, LLYVA, MEG, NVTS, PAR, REPG, REXR, RVNC, S, SILK, SITE, TXG growth, healthcare, semiconductors, small caps, software, technology, value
2023 Q3 Sep 30, 2023 Wasatch Small Cap Growth Strategy 7.6% 7.6% EEFT, FIVE, HQY, INSP, OLLI, SHAK, SILK, YETI Discount Retail, growth, healthcare, interest rates, Quality, small caps, technology SHAK
FIVE
SILK
ASIC|CWAN|INSP|KRMN|KTOS|MAC|MEG|RH|WYNN
HQY
YETI
OLLI
2022 Q3 Sep 30, 2022 Baron Discovery Fund 13.5% 9.3% AXON, CDNA, CWAN, DH, PING, RVNC, SFOR LN, SILK, SMAR, TXRH, WOOF -
2024 Q2 Jul 31, 2024 Baron Discovery Fund 13.5% 9.3% AEIS, AXON, BASE, CDXC, CHI, CYBR, DKNG, EXAS, FND, GTLB, GWRE, INSP, ITGR, KNSL, KTOS, MEG, NVMI, PAR, PCOR, SILK, SITE, STVN, TEM, TXRH AI, Diagnostics, healthcare, small caps, technology, value, volatility
2024 Q2 Jun 30, 2024 TimesSquare Capital Management U.S. Small Cap Growth Strategy 6.2% 0.0% ADUS, ATRC, AZEK, BJ, BOOT, CERT, ESAB, EWCZ, HLNE, IAC, MDIA, MRUS, MVBF, RRX, SILK, SVV, TMCI, VCTR, WRBY, WSC consumer, financials, growth, healthcare, industrials, small cap, technology
2024 Q2 Jun 30, 2024 Meridian Small Cap Growth Fund 6.2% 0.0% ACVA, AGS, ALIT, BYRN, CARG, LZ, MIR, MMSI, RBA, SILK, SMAR, STNE, TMDX, TPB downside protection, growth, Medical Devices, Quality, small caps, technology AGS
SILK
TMDX
ALIT
BYRN
LZ
2023 Q2 Jun 30, 2023 ClearBridge Investments Small Cap Growth Strategy 0.0% 0.0% AEL, ALGM, AZPN, BE, BJ, BWXT, CHGG, EYE, FIGS, FOXF, HAIN, IART, IAS, MPWR, PD, PEN, SGRE, SGRY, SILK, SPT, STAA, TREX, TRUP, XPO Biotechnology, growth, Quality, semiconductors, small caps, software, underperformance
2023 Q4 Jan 13, 2024 ClearBridge Investments Small Cap Growth Strategy 0.0% 0.0% BLKB, CHX, EYE, FOUR, FOXF, IBP, LSCC, MIRM, MPWR, NARI, NVDA, SILK, SMCI, STAA, TREX, VRNS, WHD, WING, WMT AI, Biotech, growth, healthcare, industrials, M&A, small cap, technology IBP
MIRM
BLKB
NARI

Pitches With This Ticker

Date Pitch Type Author Company Industry Sub Industry Bull / Bear Stock Exchange Keywords Action
Apr 28, 2026 Fund Letters Wasatch Small Cap Growth Strategy Silk Road Medical, Inc. Health Care Health Care Equipment & Supplies Bull NASDAQ Carotid Artery, Clinical Outcomes, CMS reimbursement, Medical devices, Standard of Care, TCAR Procedure, Vascular Surgery
Apr 13, 2026 Fund Letters Meridian Small Cap Growth Fund Silk Road Medical, Inc. Health Care Health Care Equipment & Supplies Neutral NASDAQ acquisition target, Boston Scientific, Carotid Artery, market share, Medical Device, Minimally Invasive, TCAR Procedure

BSD Shareholders of SILK

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025
Manager Name Fund Name Fund AUM Invested Value Portfolio Weight Shares Owned Shares Bought / Sold During Quarter % Bought / Sold During Quarter % of Shares Outstanding Owned
No investor data available.